Cargando…
Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer
Lung cancer is the second most common type of cancer after breast cancer. It ranks first in terms of mortality rate among all types of cancer. Lung cancer therapies are still being developed, one of which makes use of nanoparticle technology. However, conjugation with specific ligands capable of del...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467540/ https://www.ncbi.nlm.nih.gov/pubmed/36085575 http://dx.doi.org/10.1080/10717544.2022.2120566 |